Sort   by:  
 Page size 
UnknownObserved versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study.
Not available
S-EPMC9828950 | biostudies-literature
UnknownLong-Term Risk of Incident Type 2 Diabetes Following SARS-CoV-2 Infection: A Population-Based Study in British Columbia, Canada.
Not available
S-EPMC12906328 | biostudies-literature
UnknownAssociation of COVID-19 Infection With Incident Diabetes.
Not available
S-EPMC10114057 | biostudies-literature
UnknownA population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
Not available
S-EPMC10037911 | biostudies-literature
UnknownImpact of the COVID-19 Pandemic and Control Measures on Screening and Diagnoses of Type 2 Diabetes in British Columbia.
Not available
S-EPMC12026491 | biostudies-literature
UnknownComparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
Not available
S-EPMC9639791 | biostudies-literature
UnknownA multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.
Not available
S-EPMC10909657 | biostudies-literature
Sort   by:  
 Page size